GATA3 and asthma: A novel therapy for the treatment of Th2‐driven asthma targeted GATA3, a transcription factor that plays a key role in Th2 cell differentiation, through an inhaled DNA enzyme (DNAzyme) that specifically cleaves and inactivates GATA3 mRNA.